This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
General
Sort by Latest
- Sort by Latest
- Sort by Views
The Impact of the NIS2 Directive and the CER Directive for Medical Device Manufacturers and the Healthcare Sector
The rise in the volume of cyber incidents, the war in Ukraine, and the recent pandemic, has increased...
February 17, 2023
9 min read
Guide to EU and UK Pharmaceutical Regulatory Law 2023
Eighth Edition, Edited by Sally Shorthose
The Guide to EU and UK Pharmaceutical Regulatory...
January 31, 2023
3 min read
Publication of CNIL standards on health data processing implemented in the context of early access and compassionate use authorisations
The French data protection authority (Commission Nationale de l'Informatique et des Libertés...
January 16, 2023
2 min read
Rebranding generics as branded medicines – CJEU issues new guidance
The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with...
December 9, 2022
5 min read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders....
November 22, 2022
8 min read
Update on the UK’s future medical device regulations: Extended timelines
The UK’s Medicines & Healthcare products Regulatory Agency (MHRA) has recently announced the introduction...
October 31, 2022
2 min read
Blood, cells and tissues: regulatory change is coming
Approximately twenty years ago, the regulation of Substances of Human Origin (“SHO”)...
October 25, 2022
5 min read
Publication of the English version of the new French Clinical Trial Agreement templates
The French legislator recently updated the French clinical trial agreement template also called...
October 10, 2022
2 min read
Badmouthing your competitor’s products: Commission investigation indicates that so-called disparagement claims in the market could be considered stand-alone abuses of dominance
On June 20 2022, the European Commission (“Commission”) published the opening of an...
August 22, 2022
3 min read
Italy: Pharmaceutical company fined by the Italian Competition Authority for the sale of a lifesaving drug at excessive prices
Essetifin S.p.A., Leadiant Biosciences Ltd., Leadiant GmbH and Sigma – Tau Arzenmittel GmbH (“Leadiant”)...
July 18, 2022
6 min read